Innovita Biological Technology Co (SHSE:688253) Ending Cash Position : ¥543.8 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Innovita Biological Technology Co Ending Cash Position?

Innovita Biological Technology Co's Ending Cash Position for the quarter that ended in Sep. 2024 was ¥543.8 Mil.

Innovita Biological Technology Co's quarterly Ending Cash Position increased from Mar. 2024 (¥234.0 Mil) to Jun. 2024 (¥473.6 Mil) and increased from Jun. 2024 (¥473.6 Mil) to Sep. 2024 (¥543.8 Mil).

Innovita Biological Technology Co's annual Ending Cash Position declined from Dec. 2021 (¥479.7 Mil) to Dec. 2022 (¥378.7 Mil) and declined from Dec. 2022 (¥378.7 Mil) to Dec. 2023 (¥166.5 Mil).

Innovita Biological Technology Co Ending Cash Position Historical Data

The historical data trend for Innovita Biological Technology Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Innovita Biological Technology Co Ending Cash Position Chart

Innovita Biological Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

60.75

482.05

479.74

378.67

166.47

Innovita Biological Technology Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial														155.97	166.47	234.03	473.61	543.76

Innovita Biological Technology Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Innovita Biological Technology Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	378.67	+	-212.205
	=	166.5

Innovita Biological Technology Co's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	473.609	+	70.151
	=	543.8

Innovita Biological Technology Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Innovita Biological Technology Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Innovita Biological Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innovita Biological Technology Co Ltd (SHSE:688253) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1 Courtyard, Haiying Road, 1st Floor, 2nd Floor, Building 6, Fengtai District, Beijing, CHN, 100071

Website

https://www.innovita.com.cn

Innovita Biological Technology Co Ltd is a biotechnology company focusing on the research and development, production and sales of POCT in vitro diagnostic products.

Executives

Chen Fu Kang	senior management
Zhang Xiao Gang	Directors, senior managers
Zhang Xiu Jie	Directors, senior managers
Chen Ting You	Director, core technical staff
Wang Heng Qiang	Core technical personnel
Zhao Xiu Juan	Directors, senior managers
Ding Zhi	Core technical personnel

Innovita Biological Technology Co Headlines

No Headlines